Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Acute Hemolytic Transfusion Reaction

lenalidomide has been researched along with Acute Hemolytic Transfusion Reaction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adès, L; Banos, A; Beyne-Rauzy, O; Blanc, M; de Botton, S; Delaunay, J; Delmer, A; Dreyfus, F; Eclache, V; Fenaux, P; Guerci, A; Kelaidi, C; Lamy, T; Le Bras, F; Rea, D; Schmidt, A; Sebert, M; Turlure, P; Vey, N; Visanica, S1
Sekeres, MA; Tiu, RV1

Other Studies

3 other study(ies) available for lenalidomide and Acute Hemolytic Transfusion Reaction

ArticleYear
Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion--the GFM experience.
    Leukemia research, 2011, Volume: 35, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosome Deletion; Chromosomes, Human, Pair 5; Female; Humans; Lenalidomide; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Risk Factors; Thalidomide; Thrombocytopenia; Transfusion Reaction; Treatment Outcome

2011
Lenalidomide in del 5q MDS: responses and side effects revisited.
    Leukemia research, 2011, Volume: 35, Issue:11

    Topics: Antineoplastic Agents; Chromosome Deletion; Chromosomes, Human, Pair 5; Female; Humans; Lenalidomide; Male; Myelodysplastic Syndromes; Thalidomide; Transfusion Reaction

2011
Lenalidomide (Revlimid) for anemia of myelodysplastic syndrome.
    The Medical letter on drugs and therapeutics, 2006, Apr-10, Volume: 48, Issue:1232

    Topics: Anemia; Chromosome Deletion; Chromosomes, Human, Pair 5; Contraindications; Female; Humans; Lenalidomide; Myelodysplastic Syndromes; Pregnancy; Pregnancy Complications; Thalidomide; Transfusion Reaction

2006